CRAFT - Single Academic Center expeRience in Atrial Fibrillation Patients Treated With OAC
Phase of Trial: Phase IV
Latest Information Update: 30 Aug 2017
At a glance
- Drugs Acenocoumarol (Primary) ; Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Rivaroxaban (Primary) ; Warfarin (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- Acronyms CRAFT
- 30 Aug 2017 Results (n=1904) compare clinical characteristics of real-life AF patients (pts) with pts included in the randomized clinical trials (ROCKET AF and RE-LY), were presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology.
- 07 Jun 2017 Planned End Date changed from 1 Mar 2017 to 1 Sep 2017.
- 11 Feb 2017 Planned End Date changed from 1 Feb 2017 to 1 Mar 2017.